Celiac Science
Takeda Drops Another Celiac Drug — and the Pipeline Is Now Down to One
Takeda has cut a second phase 2 celiac therapy from its pipeline, leaving just one program. What the setback means for patients waiting on alternatives to the gluten-free diet.